Institutional Ownership
Janux Therapeutics Inc
CUSIP 47103J105COMJANXQ1 2026
13D / 13G Filings
51
Schedule 13D/13G on record
Beneficial Filers
17
Distinct reporting persons
Largest Stake
20.8%
Max % of class reported
Institutional Holders
182
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
51 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Janus Henderson Group PLC | 13G/A | 8.9% | 5.35M | SEC |
| 2 | Feb 9, 2026 | State Street Corporation | 13G | 6.4% | 3.85M | SEC |
| 3 | Feb 6, 2026 | Prosight Management, LP | 13G | 11.0% | 3.16M | SEC |
| 4 | Jan 8, 2026 | Fmr LLC | 13G/A | 5.8% | 3.51M | SEC |
| 5 | Nov 7, 2025 | Janus Henderson Group PLC | 13G/A | 10.0% | 6.03M | SEC |
| 6 | Aug 14, 2025 | Janus Henderson Group PLC | 13G/A | 7.5% | 4.46M | SEC |
| 7 | Aug 14, 2025 | Paradigm Biocapital Advisors LP | 13G/A | 4.9% | 9.23B | SEC |
| 8 | Aug 12, 2025 | Adage Capital Management, L.P. | 13G/A | 4.3% | 2.52M | SEC |
| 9 | Jul 17, 2025 | Blackrock, Inc. | 13G | 5.7% | 3.35M | SEC |
| 10 | May 14, 2025 | Janus Henderson Group PLC | 13G/A | 7.8% | 4.60M | SEC |
41 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Janux Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 11.19M | $155.54M |
| 2 | Blackrock, Inc. | 5.43M | $75.52M |
| 3 | Janus Henderson Group PLC | 4.20M | $58.28M |
| 4 | Prosight Management, LP | 3.55M | $49.34M |
| 5 | Fmr LLC | 2.54M | $35.25M |
| 6 | State Street Corp | 2.46M | $34.25M |
| 7 | Tcg Crossover Management, LLC | 1.79M | $24.88M |
| 8 | Alyeska Investment Group, L.P. | 1.60M | $22.26M |
| 9 | Wellington Management Group LLP | 1.60M | $22.21M |
| 10 | Deep Track Capital, LP | 1.19M | $16.50M |